Agenus (AGEN) Revenue & Revenue Breakdown

Overview ForecastOwnership Financials Chart Transcripts

Agenus Revenue Highlights

Latest Revenue (Y)

$156.31M

Latest Revenue (Q)

$25.11M

Main Segment (Y)

Non Cash Royalty Revenue

Main Geography (Y)

UNITED STATES

Agenus Revenue by Period

Agenus Revenue by Year

Date	Revenue	Change
2023-12-31	$156.31M	59.47%
2022-12-31	$98.02M	-66.85%
2021-12-31	$295.67M	235.34%
2020-12-31	$88.17M	-41.24%
2019-12-31	$150.05M	307.92%
2018-12-31	$36.78M	-14.21%
2017-12-31	$42.88M	89.95%
2016-12-31	$22.57M	-9.04%
2015-12-31	$24.82M	255.70%
2014-12-31	$6.98M	129.13%
2013-12-31	$3.04M	-80.92%
2012-12-31	$15.96M	479.18%
2011-12-31	$2.76M	-17.97%
2010-12-31	$3.36M	0.77%
2009-12-31	$3.33M	25.76%
2008-12-31	$2.65M	-52.25%
2007-12-31	$5.55M	702.20%
2006-12-31	$692.13K	9.87%
2005-12-31	$629.98K	-10.90%
2004-12-31	$707.07K	-84.11%
2003-12-31	$4.45M	30.43%
2002-12-31	$3.41M	-25.10%
2001-12-31	$4.55M	929.08%
2000-12-31	$442.63K	342.63%
1999-12-31	$100.00K	-

Agenus generated $156.31M in revenue during NA 2023, up 59.47% compared to the previous quarter, and up 424.96% compared to the same period a year ago.

Agenus Revenue by Quarter

Date	Revenue	Change
2024-09-30	$25.11M	6.82%
2024-06-30	$23.51M	-16.05%
2024-03-31	$28.00M	-66.58%
2023-12-31	$83.80M	244.66%
2023-09-30	$24.31M	-3.88%
2023-06-30	$25.30M	10.45%
2023-03-31	$22.90M	-19.32%
2022-12-31	$28.39M	24.65%
2022-09-30	$22.77M	8.82%
2022-06-30	$20.93M	-19.33%
2022-03-31	$25.94M	28.03%
2021-12-31	$20.26M	-91.99%
2021-09-30	$252.95M	2257.45%
2021-06-30	$10.73M	-8.44%
2021-03-31	$11.72M	-62.52%
2020-12-31	$31.26M	110.79%
2020-09-30	$14.83M	-44.95%
2020-06-30	$26.95M	78.11%
2020-03-31	$15.13M	-56.15%
2019-12-31	$34.50M	73.02%
2019-09-30	$19.94M	26.89%
2019-06-30	$15.71M	-80.33%
2019-03-31	$79.89M	1138.53%
2018-12-31	$6.45M	-49.62%
2018-09-30	$12.80M	-19.45%
2018-06-30	$15.89M	871.53%
2018-03-31	$1.64M	-80.42%
2017-12-31	$8.35M	148.68%
2017-09-30	$3.36M	-20.15%
2017-06-30	$4.21M	-84.39%
2017-03-31	$26.96M	383.43%
2016-12-31	$5.58M	25.42%
2016-09-30	$4.45M	-32.55%
2016-06-30	$6.59M	10.62%
2016-03-31	$5.96M	-21.99%
2015-12-31	$7.64M	11.55%
2015-09-30	$6.85M	7.39%
2015-06-30	$6.38M	61.30%
2015-03-31	$3.95M	144.16%
2014-12-31	$1.62M	3.57%
2014-09-30	$1.56M	-49.14%
2014-06-30	$3.07M	326.45%
2014-03-31	$720.86K	83.62%
2013-12-31	$392.58K	-46.66%
2013-09-30	$735.99K	-8.84%
2013-06-30	$807.40K	-27.21%
2013-03-31	$1.11M	1.75%
2012-12-31	$1.09M	25.48%
2012-09-30	$868.80K	38.61%
2012-06-30	$626.79K	-95.31%
2012-03-31	$13.37M	1977.57%
2011-12-31	$643.78K	-1.51%
2011-09-30	$653.68K	-16.88%
2011-06-30	$786.43K	17.05%
2011-03-31	$671.88K	-32.38%
2010-12-31	$993.56K	59.11%
2010-09-30	$624.45K	-22.45%
2010-06-30	$805.17K	-14.02%
2010-03-31	$936.43K	71.26%
2009-12-31	$546.79K	-39.01%
2009-09-30	$896.46K	-29.40%
2009-06-30	$1.27M	104.37%
2009-03-31	$621.35K	19.13%
2008-12-31	$521.58K	-23.81%
2008-09-30	$684.57K	15.11%
2008-06-30	$594.71K	-30.05%
2008-03-31	$850.22K	-4.82%
2007-12-31	$893.29K	-

Agenus generated $25.11M in revenue during Q3 2024, up 6.82% compared to the previous quarter, and up 99.27% compared to the same period a year ago.

Agenus Revenue Breakdown

Agenus Revenue Breakdown by Product

Annual Revenue by Product

Product/Service	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Non Cash Royalty Revenue	$114.57M	-	-	-	-
License Fee Revenue	$25.00M	-	-	-	-
Research And Development Revenue	-	$1.60M	$1.20M	$700.00K	$99.84M
Non Cash Royalty Revenue Related To The Sale Of Future Royalties And Milestone	-	$45.28M	$47.55M	$30.42M	-
Revenue	-	-	$6.70M	$4.62M	-
Product And Service Other	-	-	$184.00K	$91.00K	$4.68M
License And Service	-	-	-	-	$3.70M
Research And Development Services	-	-	-	-	$1.70M

Agenus's latest annual revenue breakdown by segment (product or service), as of Dec 23: Non Cash Royalty Revenue (82.09%), and License Fee Revenue (17.91%).

Quarterly Revenue by Product

Product/Service	Sep 24	Mar 24	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19	Jun 19
Other	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Non Cash Royalty Revenue	$24.66M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research And Development Revenue	-	-	$3.41M	$2.49M	$2.61M	$3.75M	$4.57M	$1.91M	$6.74M	$1.71M	$1.57M	$11.63M	$4.29M	$18.07M	$1.93M	$18.82M	$100.00K	$600.00K	-	-
Revenue	-	$238.00K	$540.00K	$739.00K	$1.18M	$6.35M	$1.04M	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$2.00M	$1.60M	$1.02M	-	-	-	-
Product And Service Other	-	-	-	-	-	-	-	-	-	$149.00K	-	-	$35.00K	$39.00K	-	$8.00K	$44.00K	$226.00K	$1.99M	$2.05M

Agenus's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Non Cash Royalty Revenue (98.19%), and Other (1.81%).

Agenus Revenue Breakdown by Country

Annual Revenue by Country

Country	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
UNITED STATES	$114.57M	$9.54M	$288.96M	$83.55M	$149.36M
Non Us	-	-	$6.70M	-	-
Rest Of World	-	-	-	$4.62M	-
Europe	-	-	-	-	$690.00K

Agenus's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (100.00%).

Quarterly Revenue by Country

Country	Sep 24	Mar 24	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22	Jun 22	Mar 22	Dec 21	Sep 21	Jun 21	Mar 21	Dec 20	Sep 20	Jun 20	Mar 20	Dec 19	Sep 19
Non-US	$454.00K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
UNITED STATES	$24.66M	$27.77M	$89.82M	$20.36M	$2.04M	$2.35M	$18.28M	$4.45M	$19.37M	$24.37M	$17.76M	$9.53M	$10.09M	$29.31M	$13.23M	$25.92M	$15.08M	$34.31M	$19.50M	-
Non Us	-	-	-	-	-	-	-	-	$1.56M	$1.57M	$2.50M	$1.38M	$1.20M	$1.63M	$1.95M	$1.60M	$1.02M	-	-	-
U S	-	-	-	-	-	-	-	-	-	-	-	$251.58M	-	-	-	-	-	-	-	-
Europe	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	$44.00K	$189.00K	$445.00K

Agenus's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (98.19%), and Non-US (1.81%).

Agenus Peer Comparison by Revenue

Ticker	Company	Last Year Revenue	Last Quarter Revenue
TGTX	TG Therapeutics	$233.66M	$83.88M
AGEN	Agenus	$156.31M	$25.11M
ADCT	ADC Therapeutics SA	$69.56M	$17.41M
ADAP	Adaptimmune Therapeutics	$60.28M	$128.23M
PIRS	Pieris Pharmaceuticals	$42.81M	-
MREO	Mereo BioPharma Group	$10.00M	-
AFMD	Affimed	$8.28M	$155.00K
MRKR	Marker Therapeutics	$3.31M	$1.93M
XFOR	X4 Pharmaceuticals	-	$560.00K
VKTX	Viking Therapeutics	-	-
PDSB	PDS Bio	-	-
LPTX	Leap Therapeutics	-	-
MDGL	Madrigal Pharmaceuticals	-	$62.17M
EWTX	Edgewise Therapeutics	-	-

AGEN Revenue FAQ

What is Agenus’s yearly revenue?

Agenus's yearly revenue for 2023 was $156.31M, representing an increase of 59.47% compared to 2022. The company's yearly revenue for 2022 was $98.02M, representing a decrease of -66.85% compared to 2021. AGEN's yearly revenue for 2021 was $295.66M, representing an increase of 235.34% compared to 2020.

What is Agenus’s quarterly revenue?

Agenus's quarterly revenue for Q3 2024 was $25.11M, a 6.82% increase from the previous quarter (Q2 2024), and a 3.28% increase year-over-year (Q3 2023). The company's quarterly revenue for Q2 2024 was $23.51M, a -16.05% decrease from the previous quarter (Q1 2024), and a -7.06% decrease year-over-year (Q2 2023). AGEN's quarterly revenue for Q1 2024 was $28M, a -66.58% decrease from the previous quarter (Q4 2023), and a 22.28% increase year-over-year (Q1 2023).

What is Agenus’s revenue growth rate?

Agenus's revenue growth rate for the last 3 years (2021-2023) was -47.13%, and for the last 5 years (2019-2023) was 4.18%.

What are Agenus’s revenue streams?

Agenus's revenue streams in c 23 are Non Cash Royalty Revenue, and License Fee Revenue. Non Cash Royalty Revenue generated $114.57M in revenue, accounting 82.09% of the company's total revenue License Fee Revenue generated $25M in revenue, accounting 17.91% of the company's total revenue

What is Agenus’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Agenus was Non Cash Royalty Revenue. This segment made a revenue of $114.57M, representing 82.09% of the company's total revenue.